BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26975038)

  • 1. Clinicopathologic Characterization of Aggressive Natural Killer Cell Leukemia Involving Different Tissue Sites.
    Gao LM; Zhao S; Liu WP; Zhang WY; Li GD; Küçük C; Hu XZ; Chan WC; Tang Y; Ding WS; Yan JQ; Yao WQ; Wang JC
    Am J Surg Pathol; 2016 Jun; 40(6):836-46. PubMed ID: 26975038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.
    Nicolae A; Ganapathi KA; Pham TH; Xi L; Torres-Cabala CA; Nanaji NM; Zha HD; Fan Z; Irwin S; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2017 Jan; 41(1):67-74. PubMed ID: 27631517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic features of aggressive natural killer cell leukemia].
    Liu EB; Chen HS; Zhang PH; Li ZQ; Sun Q; Yang QY; Fang LH; Sun FJ
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):810-4. PubMed ID: 22336205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.
    Li Y; Wei J; Mao X; Gao Q; Liu L; Cheng P; Liu L; Zhang X; Zhang K; Wang J; Zhu L; Zhou J; Zhang Y; Meng L; Sun H; Li D; Huang M; Huang W; Deng J; Zhang D
    PLoS One; 2016; 11(8):e0158827. PubMed ID: 27483437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and Immunophenotypic Landscape of Aggressive NK-Cell Leukemia.
    El Hussein S; Patel KP; Fang H; Thakral B; Loghavi S; Kanagal-Shamanna R; Konoplev S; Jabbour EJ; Medeiros LJ; Khoury JD
    Am J Surg Pathol; 2020 Sep; 44(9):1235-1243. PubMed ID: 32590457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent CD7 antigen loss in aggressive natural killer-cell leukemia: a useful diagnostic marker.
    Yoo EH; Kim HJ; Lee ST; Kim WS; Kim SH
    Korean J Lab Med; 2009 Dec; 29(6):491-6. PubMed ID: 20046078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic
    Savola P; Brück O; Olson T; Kelkka T; Kauppi MJ; Kovanen PE; Kytölä S; Sokka-Isler T; Loughran TP; Leirisalo-Repo M; Mustjoki S
    Haematologica; 2018 Feb; 103(2):304-312. PubMed ID: 29217783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.
    Rajala HL; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
    Ann Med; 2014 May; 46(3):114-22. PubMed ID: 24512550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.
    Jin X; Xu Y; Zhang J; Li G; Huang D; Yang Y; He H
    Diagn Pathol; 2017 Jun; 12(1):46. PubMed ID: 28623913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients.
    Barilà G; Teramo A; Calabretto G; Vicenzetto C; Gasparini VR; Pavan L; Leoncin M; Vedovato S; Frigo AC; Facco M; Semenzato G; Zambello R
    Leukemia; 2020 Apr; 34(4):1116-1124. PubMed ID: 31740810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature.
    Ryder J; Wang X; Bao L; Gross SA; Hua F; Irons RD
    Int J Hematol; 2007 Jan; 85(1):18-25. PubMed ID: 17261497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation.
    Ishida F; Ko YH; Kim WS; Suzumiya J; Isobe Y; Oshimi K; Nakamura S; Suzuki R
    Cancer Sci; 2012 Jun; 103(6):1079-83. PubMed ID: 22360679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of EBV-Negative Aggressive NK-cell Leukemia: Use of Next-Generation Sequencing in Demystifying a Diagnostic Dilemma and Guiding Clinical Care.
    Kennedy VE; Ruiz-Cordero R; Jangam D; Wen KW; Dunavin N; Ohgami RS; Bhargava P; Ai W; Fakhri B
    Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e583-e587. PubMed ID: 33814335
    [No Abstract]   [Full Text] [Related]  

  • 16. Adult aggressive natural killer cell leukemia.
    Zhang H; Meng Q; Yin W; Xu L; Lie L
    Am J Med Sci; 2013 Jul; 346(1):56-63. PubMed ID: 23241562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal immunophenotype provides a key diagnostic marker: a report of 29 cases of de novo aggressive natural killer cell leukemia.
    Li C; Tian Y; Wang J; Zhu L; Huang L; Wang N; Xu D; Cao Y; Li J; Zhou J
    Transl Res; 2014 Jun; 163(6):565-77. PubMed ID: 24524877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
    Dufva O; Kankainen M; Kelkka T; Sekiguchi N; Awad SA; Eldfors S; Yadav B; Kuusanmäki H; Malani D; Andersson EI; Pietarinen P; Saikko L; Kovanen PE; Ojala T; Lee DA; Loughran TP; Nakazawa H; Suzumiya J; Suzuki R; Ko YH; Kim WS; Chuang SS; Aittokallio T; Chan WC; Ohshima K; Ishida F; Mustjoki S
    Nat Commun; 2018 Apr; 9(1):1567. PubMed ID: 29674644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six cases of aggressive natural killer-cell leukemia in a Chinese population.
    Zhang Q; Jing W; Ouyang J; Zeng H; George SK; Liu Z
    Int J Clin Exp Pathol; 2014; 7(6):3423-31. PubMed ID: 25031771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic, Immunophenotypic, Cytogenetic, and Molecular Features of γδ T-Cell Large Granular Lymphocytic Leukemia: An Analysis of 14 Patients Suggests Biologic Differences With αβ T-Cell Large Granular Lymphocytic Leukemia. [corrected].
    Yabe M; Medeiros LJ; Wang SA; Konoplev S; Ok CY; Loghavi S; Lu G; Flores L; Khoury JD; Cason RC; Young KH; Miranda RN
    Am J Clin Pathol; 2015 Oct; 144(4):607-19. PubMed ID: 26386082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.